Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chien‐Chung Lin
Observed names:
Chien-Chung Lin,
Chienchung Lin
Institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
Observed institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
ORCID:
0000-0001-9766-2083
Observed ORCID:
0000-0001-9766-2083
OpenAlex ID:
A5072180771
The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study
2022
·
Ying-Yuan Chen
, Po-Lan Su
, et al.
·
Scientific Reports
·
13
PDF
First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer
2020
·
Po‐Lan Su
, Chian‐Wei Chen
, et al.
·
Thoracic Cancer
·
7
PDF
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer.
2023
·
Chien-Yu Lin
, Yun-Tse Chou
, et al.
·
PubMed Central
·
4
PDF
Too early to be different? A multi-institutional study with 30-year follow-up for prognostic factors of completely resected early stage thymoma
2024
·
En-Kuei Tang
, Yu-Feng Wei
, et al.
·
Journal of the Formosan Medical Association
·
3
Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort Study
2025
·
I-Lin Tsai
, Chien-Yu Lin
, et al.
·
Clinical Medicine Insights Oncology
·
2
Comparative Survival Analysis of Anti‐Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR ‐ TKI Treatment: A Retrospective Cohort Study
2025
·
Yi‐Tse Su
, Shu‐Farn Tey
, et al.
·
The Kaohsiung Journal of Medical Sciences
PDF
Abstract 3888: N-glycosylation-defective IL6 activates the SRC-YAP-SOX2 signaling to potentiate metastasis and TKI resistance in NSCLC
2023
·
Chun Hua Hung
, Shang-Yin Wu Wu
, et al.
·
Cancer Research
Abstract 192: The extracellular vesicles from lung cancer cells activates Stat3 and tumor angiogenesis
2019
·
Chien-Chung Lin
, Yu-Ting Huang
, et al.
·
Cancer Research
miR-200c in extracellular vesicles as a circulating biomarker of EGFR-TKI response and a mediator of EGFR-TKI sensitivity in heterogeneous NSCLC.
2019
·
Chienchung Lin
, Wu-Chou Su
·
Journal of Clinical Oncology
Abstract 217: The role of exosomes and exosomal miRNA in mediating EGFR-TKI sensitivity in heterogeneous NSCLC
2018
·
Chien-Chung Lin
, Wu-Chou Su
, et al.
·
Cancer Research
Abstract 3222: Metformin enhances cisplatin cytotoxicity of lung cancer through Stat3 pathway
2012
·
Chien-Chung Lin
, Hsuan-Heng Yeh
, et al.
·
Cancer Research
Abstract 1636: Anticancer drug-induced Jak2/Stat3 activation confers a survival advantage in lung cancer cells
2010
·
Wen-Pin Su
, Ya-Chin Lo
, et al.
·
Cancer Research
Show more works
View as search
Works count:
12
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type